Neurocrine Biosciences Inc (NAS:NBIX)
$ 141.335 -0.665 (-0.47%) Market Cap: 14.22 Bil Enterprise Value: 13.62 Bil PE Ratio: 38.94 PB Ratio: 5.96 GF Score: 89/100

Sosei Group Corp to Discuss Newly Announced Collaboration with Neurocrine Biosciences Investor Briefing Transcript

Nov 23, 2021 / 11:00PM GMT
Release Date Price: $87.08 (+1.26%)
Hironoshin Nomura
Sosei Group Corporation - SVP of IR & Corporate Strategy

[Interpreted] Good Morning, everyone. Thank you for joining us today despite the early morning. From now on we will start the briefing session about the license agreement with new client which was announced on day before yesterday. So I am Hironoshin Nomura, manager of IR and Corporate Strategy department for Sosei Group. (technical difficulty) moderator for today, thank you very much.

Regarding the details of the alliance, we posted an explanation [booklet] on our website a day before yesterday. So in order to answer as many questions as possible today, we will place the explanation with the video and the presentation material is posted on our Home page.

And today, we have from our company CEO, Shinichi Tamura; CFO, Chris Cargill; and Chief Medical Office Tim Tasker, all participating and present at this time.

Please check the explanation with the video and the presentation material posted on our Home page. I would like to proceed (technical difficulty) focusing on questions and answers. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot